Pharmaceutical Company Website
A professional corporate website designed for Serbia's leading pharmaceutical company, emphasizing authority, accessibility, and clear communication of products and services to diverse audiences including consumers, healthcare professionals, and industry partners.
The project focused on creating a trustworthy digital presence that reflects the company's industry leadership while ensuring easy access to critical information across all devices.
Overview
The website serves multiple stakeholder groups—patients seeking medication information, healthcare professionals requiring detailed product data, investors looking for company information, and partners exploring collaboration opportunities.
The design balances professional authority with approachability, using clean layouts, organized information architecture, and thoughtful content hierarchy to serve diverse needs without overwhelming any specific audience. Medical accuracy, regulatory compliance, and accessibility standards were paramount considerations throughout the design process.
Responsibilities
- Complete website UI/UX design in Figma
- Multi-audience information architecture
- Visual identity and corporate branding integration
- Homepage design and navigation
- Product catalog interface design
- Healthcare professional portal design
- Patient information section design
- Company information and about pages
- News and press release layouts
- Research and development showcase
- Contact and inquiry system design
- Search functionality design
- Accessibility compliance (WCAG)
- Responsive design for all devices
- Regulatory content presentation
Technical Details
The design establishes immediate credibility through professional aesthetics—refined typography, corporate color schemes, high-quality imagery, and authoritative layout structures. The visual language communicates trustworthiness and scientific rigor appropriate for a pharmaceutical industry leader.
The information architecture was carefully structured to segment content by audience type. The homepage provides clear pathways for different visitors: patients seeking medication information, healthcare professionals requiring technical data, media looking for company news, and investors accessing financial information. This audience-first navigation reduces cognitive load and accelerates path-to-information.
The product catalog employs robust organization with filtering by therapeutic area, drug name, or condition treated. Product pages balance consumer-friendly overviews with detailed prescribing information, ensuring compliance with pharmaceutical advertising regulations while serving both patient and professional audiences.
Accessibility was prioritized beyond legal compliance, recognizing that pharmaceutical information must be accessible to users with varying abilities. The design incorporates high color contrast, readable typography, clear heading hierarchies, keyboard navigation support, and screen reader compatibility—ensuring medication information reaches all who need it.
The responsive design adapts complex information layouts gracefully across devices, with mobile patterns that maintain information density without overwhelming smaller screens. Tables, charts, and data-heavy content receive special attention to remain readable and functional on mobile devices.
Trust elements are woven throughout—certifications, regulatory approvals, clinical trial data, and safety information presented transparently. The design supports scientific credibility while remaining human and approachable, particularly in patient-facing sections.
Search functionality receives prominence, recognizing that many visitors arrive seeking specific medication or therapeutic information. The design supports both general search and filtered searches within specific categories (products, news, resources).
Features
- Multi-audience content architecture
- Product catalog with filtering
- Detailed product information pages
- Healthcare professional portal
- Patient information resources
- Company history and mission
- Research and development showcase
- News and press releases
- Media center
- Investor relations section
- Career opportunities pages
- Contact and inquiry forms
- Location and office information
- Advanced search functionality
- Regulatory compliance content
- Safety and side effect information
- Accessibility features (WCAG compliant)
- Responsive mobile layouts
- Multilingual support (Serbian/English)
Technologies
- Figma
- Design Systems
- WCAG Accessibility Standards
- Corporate Design Patterns
- Responsive Design
- Information Architecture
- Component Libraries
- Professional Photography
Outcome
The website successfully established a digital presence befitting Serbia's leading pharmaceutical company, balancing regulatory requirements with user-friendly design that serves diverse audiences effectively.
The clear information architecture reduced bounce rates and improved task completion, with users reporting easier access to medication information, prescribing details, and company resources. The audience-segmented navigation addressed the challenge of serving vastly different user needs within a single site.
Accessibility compliance ensured pharmaceutical information reaches all users regardless of ability, aligning with the company's healthcare mission while meeting legal requirements. Healthcare professionals particularly appreciated the easy access to detailed product data and clinical information.
The professional design elevated brand perception, reinforcing the company's position as an industry leader and trusted healthcare partner. The modern, clean aesthetic updated the company's digital image while maintaining the authority and credibility essential in pharmaceutical communications.
The responsive design ensured consistent experience across devices, important for healthcare professionals accessing information during clinical settings and patients researching medications from various devices. The project demonstrated expertise in designing for regulated industries where accuracy, accessibility, and trust are paramount.